Valerian () root contains mono- and sesquiterpenes, and iridoid triesters (valepotriates). Preparations are sometimes standardized on valerenic acid content. Valerian has no specific uses in nursing mothers, but is most commonly used to treat anxiety and sleep disturbances, and occasionally for self-treatment of postpartum blues or depression.[1,2] No data exist on the safety and efficacy of valerian in nursing mothers or infants. In general, valerian is well tolerated, with side effects such as dizziness, hangover or headache reported occasionally. Valerian is "generally recognized as safe" (GRAS) for use in food by the U.S. Food and Drug Administration. Valerian is often not recommended during lactation because of the theoretical concerns over its valepotriates and baldrinals which have been shown to be cytotoxic and mutagenic in vitro. Because there is no published experience with valerian during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information about dietary supplements is available elsewhere on the LactMed Web site.
缬草根含有单萜和倍半萜以及环烯醚萜三酯(缬草三酯)。制剂有时会根据缬草酸含量进行标准化。缬草在哺乳期母亲中没有特定用途,但最常用于治疗焦虑和睡眠障碍,偶尔也用于自我治疗产后情绪低落或抑郁症。[1,2] 关于缬草在哺乳期母亲或婴儿中的安全性和有效性尚无数据。一般来说,缬草耐受性良好,偶尔会有头晕、宿醉或头痛等副作用报告。美国食品药品监督管理局认为缬草 “一般公认为安全”(GRAS),可用于食品。由于理论上担心其缬草三酯和巴德林纳,缬草在哺乳期通常不被推荐,这些物质在体外已被证明具有细胞毒性和致突变性。由于母乳喂养期间没有关于缬草的已发表经验,替代疗法可能更受青睐,尤其是在喂养新生儿或早产儿期间。膳食补充剂不需要美国食品药品监督管理局进行广泛的上市前批准。制造商有责任确保安全,但在膳食补充剂上市前不需要证明其安全性和有效性。膳食补充剂可能含有多种成分,标签成分与实际成分或其含量之间往往存在差异。制造商可能会与独立组织签订合同,以验证产品或其成分的质量,但这并不能证明产品的安全性或有效性。由于上述问题,一种产品的临床试验结果可能不适用于其他产品。有关膳食补充剂的更详细信息可在LactMed网站的其他地方获取。